Figure 2From: Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials Comparison of relative risk (95% confidence interval) for clinical response rates in patients with MDD: quetiapine vs. placebo. Back to article page